JMP Securities Upgrades Vitae Pharmaceuticals (VTAE) to Market Outperform
Tweet
Share
E-mailGet Alerts VTAE Hot Sheet
Price: $21.00 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 6
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 6
Join SI Premium – FREE
JMP Securities upgraded Vitae Pharmaceuticals (NASDAQ: VTAE) from Market Perform to Market Outperform.
For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.
Shares of Vitae Pharmaceuticals closed at $4.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Avantor Inc. (AVTR) to Peerperform
- Keefe, Bruyette & Woods Upgrades Lemonade Inc. (LMND) to Market Perform
- Baird Upgrades Werner Enterprises (WERN) to Outperform
Create E-mail Alert Related Categories
Momentum Movers, UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
